Almost 4 billion prescriptions for medications were written in the United States in 2010, an all-time high.
Each single dose prefilled syringe contains 300mcg (1500 IU) of Rho(D) immune globulin (human). This is the dose for the indications associated w/ pregnancy at or beyond 13 weeks unless there is clinical or laboratory evidence of a fetal-maternal hemorrhage (FMH) >15mL of Rh-positive RBCs. MICRhoGAM. Each single dose prefilled syringe of MICRhoGAM contains 50mcg (250 IU) of Rho(D) immune globulin (human).
If an Rh-negative pregnant woman is carrying an Rh-positive fetus, the fetus may be at risk of hemolytic disease of the newborn, in which antibodies made by the mother against the Rh antigen may cross the placenta and destroy the fetus's red blood cells. RhoGAM administered to pregnant Rh- women may prevent this disease.